BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 33310157)

  • 1. Functional and Biochemical Consequences of Disease Variants in Neurotransmitter Transporters: A Special Emphasis on Folding and Trafficking Deficits.
    Bhat S; El-Kasaby A; Freissmuth M; Sucic S
    Pharmacol Ther; 2021 Jun; 222():107785. PubMed ID: 33310157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotransmitter transporters in schistosomes: structure, function and prospects for drug discovery.
    Ribeiro P; Patocka N
    Parasitol Int; 2013 Dec; 62(6):629-38. PubMed ID: 23800409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and Clinical Repercussions of GABA Transporter 1 Variants Gone Amiss: Links to Epilepsy and Developmental Spectrum Disorders.
    Fischer FP; Kasture AS; Hummel T; Sucic S
    Front Mol Biosci; 2022; 9():834498. PubMed ID: 35295842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An unfolding story: Small molecules remedy misfolded monoamine transporters.
    Kasture A; Stockner T; Freissmuth M; Sucic S
    Int J Biochem Cell Biol; 2017 Nov; 92():1-5. PubMed ID: 28890376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Creatine Transporter Unfolded: A Knotty Premise in the Cerebral Creatine Deficiency Syndrome.
    Farr CV; El-Kasaby A; Freissmuth M; Sucic S
    Front Synaptic Neurosci; 2020; 12():588954. PubMed ID: 33192443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rescue by 4-phenylbutyrate of several misfolded creatine transporter-1 variants linked to the creatine transporter deficiency syndrome.
    El-Kasaby A; Kasture A; Koban F; Hotka M; Asjad HMM; Kubista H; Freissmuth M; Sucic S
    Neuropharmacology; 2019 Dec; 161():107572. PubMed ID: 30885608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When transporters fail to be transported: how to rescue folding-deficient SLC6 transporters.
    Sucic S; Kasture A; Mazhar Asjad HM; Kern C; El-Kasaby A; Freissmuth M
    J Neurol Neuromedicine; 2016 Dec; 1(9):34-40. PubMed ID: 28405636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SLC6 Transporter Folding Diseases and Pharmacochaperoning.
    Freissmuth M; Stockner T; Sucic S
    Handb Exp Pharmacol; 2018; 245():249-270. PubMed ID: 29086036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining the blanks--pharmacochaperoning of SLC6 transporters and ABC transporters.
    Chiba P; Freissmuth M; Stockner T
    Pharmacol Res; 2014 May; 83(100):63-73. PubMed ID: 24316454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric Modulation of Neurotransmitter Transporters as a Therapeutic Strategy.
    Niello M; Gradisch R; Loland CJ; Stockner T; Sitte HH
    Trends Pharmacol Sci; 2020 Jul; 41(7):446-463. PubMed ID: 32471654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relax, Cool Down and Scaffold: How to Restore Surface Expression of Folding-Deficient Mutant GPCRs and SLC6 Transporters.
    Asjad HMM; Nasrollahi-Shirazi S; Sucic S; Freissmuth M; Nanoff C
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29135937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SLC6 neurotransmitter transporters: structure, function, and regulation.
    Kristensen AS; Andersen J; Jørgensen TN; Sørensen L; Eriksen J; Loland CJ; Strømgaard K; Gether U
    Pharmacol Rev; 2011 Sep; 63(3):585-640. PubMed ID: 21752877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligomerization of neurotransmitter transporters: a ticket from the endoplasmic reticulum to the plasma membrane.
    Farhan H; Freissmuth M; Sitte HH
    Handb Exp Pharmacol; 2006; (175):233-49. PubMed ID: 16722239
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Kasture AS; Fischer FP; Kunert L; Burger ML; Burgstaller AC; El-Kasaby A; Hummel T; Sucic S
    Front Neurosci; 2022; 16():1074427. PubMed ID: 36741049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiology and Pharmacology of Neurotransmitter Transporters.
    Ayala-Lopez N; Watts SW
    Compr Physiol; 2021 Jun; 11(3):2279-2295. PubMed ID: 34190339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacochaperoning in a
    Asjad HMM; Kasture A; El-Kasaby A; Sackel M; Hummel T; Freissmuth M; Sucic S
    J Biol Chem; 2017 Nov; 292(47):19250-19265. PubMed ID: 28972153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the carboxyl-terminal SEC24 binding motif of the serotonin transporter impair folding of the transporter.
    El-Kasaby A; Just H; Malle E; Stolt-Bergner PC; Sitte HH; Freissmuth M; Kudlacek O
    J Biol Chem; 2010 Dec; 285(50):39201-10. PubMed ID: 20889976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trafficking of vesicular neurotransmitter transporters.
    Fei H; Grygoruk A; Brooks ES; Chen A; Krantz DE
    Traffic; 2008 Sep; 9(9):1425-36. PubMed ID: 18507811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional Rescue of a Misfolded
    Kasture A; El-Kasaby A; Szöllősi D; Asjad HMM; Grimm A; Stockner T; Hummel T; Freissmuth M; Sucic S
    J Biol Chem; 2016 Sep; 291(40):20876-20890. PubMed ID: 27481941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SLC6 transporter oligomerization.
    Jayaraman K; Das AK; Luethi D; Szöllősi D; Schütz GJ; Reith MEA; Sitte HH; Stockner T
    J Neurochem; 2021 May; 157(4):919-929. PubMed ID: 32767560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.